Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,260,199
-$22,866 QoQ
Shares Held
4,962
-5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,778
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Wealth Planning, LLC holds $1,476,062,154 across 7 Drug Manufacturers - General names. JNJ ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
2,033,759 | $736,464,808 | |
| 2 | MRK |
Merck & Co., Inc.
|
4,708,599 | $605,054,971 | |
| 3 | LLY |
ELI LILLY & Co
|
39,748 | $47,674,946 | |
| 4 | AZN |
Astrazeneca PLC
|
215,993 | $40,956,591 | |
| 5 | NVS |
Novartis AG
|
151,974 | $23,817,364 | |
| 6 | ABBV |
AbbVie Inc.
|
82,790 | $20,833,275 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
4,962 | $1,260,199 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,260,199 | 4,962 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,283,065 | 5,249 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,020,884 | 4,933 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $950,833 | 5,128 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $859,371 | 5,626 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $836,828 | 5,046 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $934,968 | 6,465 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,932,727 | 11,926 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,891,164 | 12,939 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,511,027 | 22,195 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $244,872,236 | 1,562,283 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $239,812,324 | 1,539,726 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $425,574,264 | 2,571,135 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $371,867,320 | 2,399,144 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $367,733,717 | 2,081,708 | Shares | Other | 2023-02-03 | |
| 2022-09-30 | $300,355,655 | 1,838,612 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $291,303,850 | 1,641,056 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $162,444,586 | 916,575 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $137,486,392 | 803,685 | Shares | Other | 2022-02-04 | |
| 2021-09-30 | $187,444,490 | 1,160,647 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $177,084,956 | 1,074,936 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $155,637,806 | 946,990 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $72,439,180 | 460,282 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $55,108,676 | 370,155 | Shares | Other | 2020-11-10 | |
| 2020-06-30 | $47,119,627 | 335,061 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $61,990,002 | 472,737 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||